US 10544232
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10544232 (Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K39/3955, A61P